These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16179805)

  • 1. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis.
    Monkawa T; Pippin J; Yo Y; Kopp JB; Alpers CE; Shankland SJ
    Nephron Exp Nephrol; 2006; 102(1):e8-18. PubMed ID: 16179805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis.
    Kim YG; Alpers CE; Brugarolas J; Johnson RJ; Couser WG; Shankland SJ
    Kidney Int; 1999 Jun; 55(6):2349-61. PubMed ID: 10354282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen peroxide-inducible clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice.
    Jamba A; Kondo S; Urushihara M; Nagai T; Kim-Kaneyama JR; Miyazaki A; Kagami S
    PLoS One; 2015; 10(4):e0122773. PubMed ID: 25835392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
    Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
    Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
    Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
    Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.
    Daniel C; Pippin J; Shankland SJ; Hugo C
    Lab Invest; 2004 May; 84(5):588-96. PubMed ID: 15064772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.
    Pippin JW; Qu Q; Meijer L; Shankland SJ
    J Clin Invest; 1997 Nov; 100(10):2512-20. PubMed ID: 9366565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis.
    Morita Y; Nomura A; Yuzawa Y; Nishikawa K; Hotta N; Shimizu F; Matsuo S
    J Am Soc Nephrol; 1997 Sep; 8(9):1363-72. PubMed ID: 9294827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway.
    Hiromura K; Monkawa T; Petermann AT; Durvasula RV; Shankland SJ
    Kidney Int; 2002 Apr; 61(4):1312-21. PubMed ID: 11918738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mouse model of immune-mediated podocyte injury.
    Meyer TN; Schwesinger C; Wahlefeld J; Dehde S; Kerjaschki D; Becker JU; Stahl RA; Thaiss F
    Kidney Int; 2007 Oct; 72(7):841-52. PubMed ID: 17653132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
    J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular expression of hydrogen peroxide-inducible clone-5 in human and rat progressive mesangial proliferative glomerulonephritis.
    Suga K; Kondo S; Matsuura S; Kinoshita Y; Urushihara M; Kagami S
    Nephron Exp Nephrol; 2012; 120(2):e59-68. PubMed ID: 22286178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Nephron; 1998; 79(2):206-14. PubMed ID: 9647502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.